[PDF][PDF] Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in …

KI Pritchard, LE Shepherd, JA Chapman, BD Norris… - J Clin Oncol, 2011 - mcgill.ca
KI Pritchard, LE Shepherd, JA Chapman, BD Norris, J Cantin, PE Goss, SF Dent, D Walde…
J Clin Oncol, 2011mcgill.ca
Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in
the Adjuvant Treatment of Early-Stage Brea Page 1 Randomized Trial of Tamoxifen Versus
Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage
Breast Cancer in Postmenopausal Women: NCIC CTG MA.14 Kathleen I. Pritchard, Lois E.
Shepherd, Judith-Anne W. Chapman, Brian D. Norris, Jacques Cantin, Paul E. Goss, Susan F.
Dent, David Walde, Ted A. Vandenberg, Brian Findlay, Susan E. O’Reilly, Carolyn F. Wilson …
Purpose
Somatostatin analogs act directly on breast cancer cells and indirectly on insulin and insulin-like growth factor 1 (IGF-1) levels. This trial was undertaken to assess whether octreotide would lower insulin and IGF-1 levels and reduce risk of breast cancer recurrence.
mcgill.ca